TrialBlood2019
Ibrutinib therapy downregulates AID enzyme and proliferative fractions in chronic lymphocytic leukemia.
Pablo Elías Morande et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papercites it
TrialBlood2019
Pablo Elías Morande et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.